Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02130466 |
|---|---|
| Brief Title: | A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) |
| First Submitted : | May 1, 2014 |
| First Submitted that Met QC Criteria : | May 1, 2014 |
| First Posted : | May 5, 2014 (Estimate) |
| Results First Submitted : | June 30, 2022 |
| Results First Submitted that Met QC Criteria : | June 30, 2022 |
| Results First Posted : | August 1, 2022 |
| Last Update Submitted that Met QC Criteria : | June 30, 2022 |
| Last Update Posted : | August 1, 2022 |